Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitya Shree

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Pageof 2